Bristol-Myers Squibb and Harvard Announce New Fibrosis Research Collaboration

Bristol-Myers Squibb Company and the Harvard Fibrosis Network of the Harvard Stem Cell Institute today announce a research collaboration to discover and develop potential new therapies for fibrotic diseases, including fibrosis of the liver and heart. The Harvard Fibrosis Network brings together researchers across the schools and affiliated hospitals of Harvard University.

• Source: news.bms
• 609
• April 13, 2018